Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lazarus

Showing results (691-700 of 1,048) with videos related to

Pageof 105
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials NetworkGinna G Laport, Juan Wu, Brent Logan, et al.
Leukemia & Lymphoma|December 5, 2017
Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantationAnand Tandra, Fahrettin Covut, Brenda Cooper, et al.
The New England Journal of Medicine|July 4, 2003
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancerMartin S Tallman, Robert Gray, Nicholas J Robert, et al.
Annals of Internal Medicine|October 3, 2000
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry reportP J Stiff, J Veum-Stone, H M Lazarus, et al.
The Journal of Clinical Investigation|September 7, 2000
Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuriaR Chen, S Nagarajan, G M Prince, et al.
Organic & Biomolecular Chemistry|October 27, 2020
Fusarochromene, a novel tryptophan-derived metabolite from <i>Fusarium sacchari</i>James W Marshall, Kate M J de Mattos-Shipley, Iman A Y Ghannam, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Bone Marrow Transplantation|December 3, 2024
Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I studyJoseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Bone Marrow Transplantation|July 3, 2003
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancerJ D Rizzo, S Williams, J T Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profileK K Fields, G J Elfenbein, H M Lazarus, et al.
Pageof 105

Showing results (691-700 of 1,048) with videos related to

Sort By:
Pageof 105
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2016
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials NetworkGinna G Laport, Juan Wu, Brent Logan, et al.
Leukemia & Lymphoma|December 5, 2017
Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantationAnand Tandra, Fahrettin Covut, Brenda Cooper, et al.
The New England Journal of Medicine|July 4, 2003
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancerMartin S Tallman, Robert Gray, Nicholas J Robert, et al.
Annals of Internal Medicine|October 3, 2000
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry reportP J Stiff, J Veum-Stone, H M Lazarus, et al.
The Journal of Clinical Investigation|September 7, 2000
Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuriaR Chen, S Nagarajan, G M Prince, et al.
Organic & Biomolecular Chemistry|October 27, 2020
Fusarochromene, a novel tryptophan-derived metabolite from <i>Fusarium sacchari</i>James W Marshall, Kate M J de Mattos-Shipley, Iman A Y Ghannam, et al.
Blood|March 19, 2011
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinHugo F Fernandez, Zhuoxin Sun, Mark R Litzow, et al.
Bone Marrow Transplantation|December 3, 2024
Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I studyJoseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Bone Marrow Transplantation|July 3, 2003
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancerJ D Rizzo, S Williams, J T Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profileK K Fields, G J Elfenbein, H M Lazarus, et al.
Pageof 105